Lead Product(s): Modified Cyclodextrin
Therapeutic Area: Infections and Infectious Diseases Product Name: Captisol
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: Ligand Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership September 23, 2020
The partnership aims to significantly ramp up the production output of Captisol®. Captisol®, a Ligand product and a chemically modified cyclodextrin proven to improve the solubility and stability of drugs.